0 citations
Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia
International Journal of Clinical Pharmacology and Therapeutics2015Vol. 54(01), pp. 19–27
Citations Over TimeTop 10% of 2015 papers
Maurizio Caserini, Milko Radicioni, Chiara Leuratti, Emanuela Terragni, Matilde Iorizzo, Renata Palmieri
Abstract
The novel finasteride 0.25% solution applied o.d. at the doses of 100 and 200 μL results in an appropriate inhibition of scalp DHT potentially minimizing the untoward sexual side-effects linked to a systemic DHT reduction.
Related Papers
- → The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.(1994)197 cited
- → The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness(1994)89 cited
- → Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia(1999)42 cited
- → 28108 Untargeted metabolomics and steroid signatures in urine of male pattern baldness patients after finasteride treatment for a year(2021)1 cited
- → 5 α -Reductase Inhibitors in the Treatment of Androgenetic Alopecia(2001)